These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3777587)

  • 1. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.
    Lim DT; Singh P; Nourtsis S; Dela Cruz R
    Ann Emerg Med; 1986 Nov; 15(11):1303-7. PubMed ID: 3777587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA; Glucksman E; Henry JA
    Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA; Henry JA
    J Toxicol Clin Toxicol; 1995; 33(1):43-9. PubMed ID: 7837312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of theophylline toxicity with oral activated charcoal.
    Sessler CN; Glauser FL; Cooper KR
    Chest; 1985 Mar; 87(3):325-9. PubMed ID: 3971756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated charcoal surface area and its role in multiple-dose charcoal therapy.
    Ilkhanipour K; Yealy DM; Krenzelok EP
    Am J Emerg Med; 1993 Nov; 11(6):583-5. PubMed ID: 8240556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
    Weinberger M; Hendeles L; Wong L
    J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the surface area of activated charcoal on theophylline clearance.
    Park GD; Spector R; Goldberg MJ; Johnson GF; Feldman R; Quee CK
    J Clin Pharmacol; 1984 Jul; 24(7):289-92. PubMed ID: 6480875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-bowel irrigation as adjunctive treatment for sustained-release theophylline overdose.
    Burkhart KK; Wuerz RC; Donovan JW
    Ann Emerg Med; 1992 Nov; 21(11):1316-20. PubMed ID: 1416325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
    Harrison LI; French IW; Mildon CA
    Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline absorption by effervescent activated charcoal (Medicoal).
    Helliwell M; Berry D
    J Int Med Res; 1981; 9(3):222-5. PubMed ID: 7238997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.
    Simons KJ; Frith EM; Simons FE
    J Pharm Sci; 1982 May; 71(5):505-11. PubMed ID: 7097493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline absorption in young asthmatic children receiving sustained-release formulations.
    Haltom JR; Szefler SJ
    J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged toxicity following massive ingestion of sustained-release theophylline preparation.
    Corser BC; Youngs C; Baughman RP
    Chest; 1985 Nov; 88(5):749-50. PubMed ID: 4053717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.